Mark Holterman, MD
1.) Cox TD, Winters WD, Holterman MJ, Hatch EI, and Skarin RM, "Neonatal bowel ischemia attributable to an umbilical arteriovenous fistula: imaging findings", Am J Roentgenology 165(4):940-2, (1995).
2.) Waldhausen JHT, Holterman MJ and Tapper D., "Identification and Surgical Management of Cystic Retroperitoneal Lymphangiomas in Children", Ped Surg Int. 11:283-85, (1996).
3.) Waldhausen JHT, Holterman MJ and Sawin RS, "Surgical Implications of Necrotizing Fasciitis in Children with Chicken Pox", J Ped Surg, 31:1138-41,(1996).
4.) Yu J, Zhao Y, Holterman MJ, Venton DL (1999) Combinatorial search of substituted beta-cyclodextrins for phosphatase-like activity. Bioorg Med Chem Lett;9(18): 2705-10.
5.) Chin A, Stich D, White F, Radhakrishnan J and Holterman MJ (2001) Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass. J of Ped. Surg.,2001 Dec 36 (12) :E22.
6.) Rao S, Vasu C, Martinez O, Kaithamana S, Prabhakar BS and Holterman MJ. (2001) Targeted delivery of anti-CTLA4 antibody downregulates T cell function in vitro and in vivo. Clin. Immunol.2001 Nov 101(2): 136-145.
7.) Vasilevko V, Ghochikyan A, Holterman MJ, Agadjanyan MG., CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHA. DNA Cell Biol 2002 Mar; 21(3): 137-49.
8.) Vasu C, Wang A, Gorla SR, Kaithamana S, Prabhakar BS and Holterman M.J. CD80 C-domain enhances T cell inhibition by increasing binding to CTLA-4 (CD152) Int Immunol. 2003 Feb;15(2):167-75.
9.) Vasu C, Dogan RE, Holterman M.J. and Prabhakar BS. Selective induction of dendritic cells using GM-CSF, but not Flt3-L, activates thyroglobulin specific CD4+/CD25+ T cells and suppresses experimental autoimmune thyroiditis J Immunol. 2003 Jun 1;170(11):5511-22
10.) Dogan RN, Vasu C, Holterman MJ, Prabhakar BS. Absence of IL-4, and not Suppression of Th2 Response, Prevents Development of Experimental Autoimmune Graves’ Disease . J Immunol. 2003 Feb 15;170(4):2195-204.
11.) Vasu C, Gorla SR, Prabhakar BS and Holterman MJ. (2003) Targeted engagement of CTLA-4 prevents autoimmune thyroiditis, Int. Immunol Int Immunol. 2003 May;15(5):641-54.
12.) Y J, Zhao Y, Holterman MJ, Venton DL. (2002) Cocaine detoxification by combinatorially substituted beta-cyclodextrin libraries. Biorg Med Chem. 2002 Oct; 10 (10):3291-9.
13.) Yu J, Bakhos L, Chang L. Holterman MJ, Klein WL, Venton DL. (2002) Per-6-substitued beta-cycodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomers. J Mol Neurosci. 2002 Aug-Oct;19(1-2):51-5.
14.) Agadjanyan MG, Chattergoon MA, Holterman MJ, Monzavi-Karbassi B, Kim JJ, Dentchev T, Wilson D, Ayyavoo V, Montaner LJ, Kieber-Emmons T, Sekaly RP, Weiner DB. Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86. J Immunol. 2003 Oct 15;171(8):4311-9.
15.) Holterman MJ, Holterman AL, Carrol R, John E, Testa G, Sankary H, Cohen M, Grevious M, Abcarian HA, Benedetti E. Living-related bowel transplantation to treat short bowel syndrome in a four-year-old child: a case report. J Pediatr Surg. 2003 Dec;38(12):1763-5.
16.) Vasu C, Holterman MJ, Prabhakar BS. Modulation of dendritic cell function and cytokine production to prevent thyroid autoimmunity. Autoimmunity. 2003 Sep-Nov;36(6-7):389-96.
17.) Abdulla R, Blew GA and Holterman MJ, Cardiovascular embryology. Pediatr Cardiol. 2004 May-Jun;25(3):191-200.
18.) Short JJ, Pereboev AV, Kawakami Y, Vasu C, Holterman MJ, Curiel DT. Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. Virology. 2004 May 1;322(2):349-59.
19.) Vasu C, Prabhakar BS, Holterman MJ. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity. J Immunol. 2004 Aug 15;173(4):2866-76.
20.) Talisetti A, Jelnin V, Ruiz C, John E, Benedetti E, Testa G, Holterman AL, Holterman MJ: Electron Beam CT scan is a Valuable and Safe Imaging Tool for the Pediatric Surgical Patient J Pediatr Surg. 2004 Dec;39(12):1859-62.
21.) Horgan S, Holterman MJ, Jacobsen GR, Browne AF, Berger RA, Moser F, Holterman AX. Laparoscopic adjustable gastric banding for the treatment of adolescent morbid obesity in the US: A safe alternative to gastric bypass. J Pediatr Surg. 2005 Jan;40(1):86-90.
22.) Testa G, Panaro F, Schena S, Holterman M, Abcarian H, Benedetti E. Living related small bowel transplantation: donor surgical technique. Ann Surg. 2004 Nov;240(5):779-84.
23.) Testa G, Holterman M, John E, Kecskes S, Abcarian H, Benedetti E. Combined living donor liver/small bowel transplantation. Transplantation 2005; 79(10): 1401-1404.
24.) Talisetti, A, Testa G, Holterman M, John E, Kecskes S, Benedetti E, Successful treatment of posttransplant lymphoproliferative disorder with removal of small bowel graft and subsequent second bowel transplant. J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):354-6.
25.) Porubsky M, Testa G, John E, Holterman M, Tsou M, Benedetti E, Pattern of growth after pediatric living-donor small bowel transplantation. Pediatr Transplant. 2006 Sep;10(6):701-6.
26.) Short JJ, Vasu C, Holterman MJ, Curiel DT, Pereboev A. Members of adenovirus species B utilizes CD80 and CD86 as cellular attachment receptors. Virus Res. 2006 Dec;122(1-2):144-53
Allen Browne, MD - Publications
1. Browne, AF, & Sager, GF (1980). Cystosarcoma phyllodes. Journal of the Maine Medical Association, 77:339-340.
2. Browne, AF, Martin, LW, Miller, EH, & Rosenkrantz, JG (1981). Extra-anatomical vascular bypass and external skeletal fixation in limb replantation. Journal of Pediatric Surgery, 16:306-308.
3. King, DR, Browne, AF, Birken, GA, Hilty, MD, Kerzner, B, & Boles Jr, ET (1983). Antibiotic management of complicated appendicitis. Journal of Pediatric Surgery, 18:945-949.
4. Browne, AF, Katz, S, Miser, J, & Boles, Jr ET (1983). Blue rubber bleb nevi as a cause of intussusception. Journal of Pediatric Surgery, 18:7-9.
5. Abajian, JC, Mellish, RWP, Browne, AF, Perkins, FM, Lambert, DH, & Mazuzan Jr, JE (1984). Spinal anesthesia for surgery in the high risk infant. Anesthesia and Analgesia, 63:359-362.
6. Caniano, DA, Boles Jr, ET, & Browne, AF (1985). Pancreatic pseudocyst
complicating treatment of acute lymphoblastic leukemia. Journal of Pediatric
Surgery, 20(4):452-455.
7. Krisher, SL, Browne, A, Dibbins, A, Tkacz, N, & Curci, M. (2001).
“Intra-abdominal abscess after laparoscopic appendectomy for perforated appendicitis.” Archives of Surgery, 136:438-441.
8. Browne, AF, Stahl, C, Holterman, AL, Tkacz, NJ, & Holterman, MJ. (2004). “Morbidly Obese Adolescents-Who are they? Where are they going? What can be done?” Illinois Pediatrician, August.
9. Horgan, S., Holterman, M.J., Jacobson, F.R., Browne, A.F., Berger, R.A.,Moser, F., & Holterman, A.L. (2005). Laparoscopic adjustable gastric banding for the treatment of adolescent morbid obesity in the United States: a safe alternative to gastric bypass. Journal of Pediatric Surgery. 40(1), 86-90.
Aixuan Holterman, MD
Selected Publications
1.Holterman AL*, Filiatrault D, Lallier M and Youssef, S (1998) The natural history of Sacrococcygeal Teratomas diagnosed through routine obstetric sonogram: a single institution experience. J. Pediatr Surg 33(6): 1-6.
2.Shah SI, Licamelli G, and Holterman AL* (2000) Congenital Cervical Teratoma with associated Tracheomalacia: Airway Management and Complications. Otolaryngology Head Neck Surg 124(1):53-55
3.Holterman AL*, Rogers K, Edelman K, Koelle DM, Corey L and Wilson CB (1999) An important role for MHC class I restricted T cell, and limited role for IFN-g in protection against lethal Herpes Simplex virus infection in C57BL/6 mice. J. Virology 73(3): 2058-63.
4.Honggang Ye, A Holterman, Kyung W Yoo, Roberta Franks and Robert H. Costa (1999) Premature Expression of the Winged Helix Transcription Factor HFH-11B in Regenerating Mouse Liver accelerates Hepatocyte entry into S-Phase. Mol Cell Biol 19 (12): 8570-8580
5. Holterman AL*, Yong Jun Tan, Woo Ram Kim and Robert H Costa (2002) Diminished expression of Hepatocyte Nuclear Factor HNF-6 (OC-1) in the mouse bile duct epithelia during bile duct obstruction.Hepatology35(6):1392-9
6. Costa RH, Kalinichenko V and Holterman AL. (2003) Transcription factors in liver development, differentiation and regeneration. Hepatology Dec;38(6):1331-47
7. Wang M, Tan YJ, Costa RH and Holterman AL* (2004) In vivo transcriptional regulation of the hepatic Cholesterol 7-a hydroxylase (CYP7A1) gene by Hepatocyte Nuclear Factor 6: A novel mechanism for diminishing CYP7A1 expression during biliary obstruction. Hepatology Sept; 40(3): 600-608.
8. Santiago Horgan, Mark J. Holterman, Garth R. Jacobsen, Allen F. Browne, Robert A. Berger, Federico Moser and Ai-Xuan L. Holterman* (2005) Laparoscopic adjustable gastric banding for the treatment of adolescent morbid obesity in the U.S.: a safe alternative to gastric bypass. J Pediatr. Surgery; 40(1):86-91
9. Holterman A*, Adams K, and Seeler, R (2006) Surgical management of hematologic disorders. Surg Clinics North America 86(2):427-439.
10.Holterman A*, Browne A, , Dillard III B, Tussing L, Galvani C, Labott S, Herdegen J, Guzman G, Rink A, Nwaffo I, Gorodner V, Browne N, Horgan S. and Holterman M (2007) Short term outcome for the first 10 patients in the laparoscopic adjustable gastric banding FDA trial for morbidly obese adolescents J Pediatr.Gastroenterol. Nutr. (Accepted)
